Anxiety is one of the most common mental health disorders in the world, affecting over 301 million people globally as of 2019, according to the World Health Organization (WHO).[1] In the United States alone, anxiety disorders affect approximately 19.1% of adults every year.[2] Given the wide-ranging impact of anxiety and its various forms—from generalized anxiety disorder to panic disorder—effective treatment is a priority for healthcare providers and patients alike.

One medication that often enters the conversation around anxiety treatment is Pristiq. Though primarily used to treat major depressive disorder (MDD), many wonder whether Pristiq can help treat anxiety, especially when symptoms of depression and anxiety overlap. In this article, we’ll explore what Pristiq is, how it works, and whether it plays a role in managing anxiety symptoms.

What is Pristiq?

Pristiq (desvenlafaxine) is an FDA-approved prescription medication primarily used to treat major depressive disorder (MDD) in adults. It belongs to a class of antidepressant drugs known as serotonin-norepinephrine reuptake inhibitors (SNRIs). These medications work by increasing the levels of serotonin and norepinephrine—two neurotransmitters that play a crucial role in regulating mood and emotional health.

Unlike selective serotonin reuptake inhibitors (SSRIs), which target only serotonin, SNRIs like Pristiq target both serotonin and norepinephrine, potentially offering broader symptom relief for people with comorbid anxiety and depression.

How Pristiq Works in the Brain

Pristiq works by blocking the reuptake of serotonin and norepinephrine in the brain. This action allows these neurotransmitters to remain in the brain longer, which can help regulate mood, reduce somatic symptoms like muscle tension or sleep disturbances, and potentially improve focus and emotional stability.

This mechanism is important in both depression and anxiety treatment, as low levels of serotonin and norepinephrine are associated with persistent anxiety, panic attacks, and other severe anxiety symptoms.

Pristiq for Anxiety: Is it Effective?

Not FDA-Approved for Anxiety

To date, Pristiq is not FDA-approved for treating anxiety disorders, including generalized anxiety disorder (GAD), panic disorder, or social anxiety disorder. However, that does not mean it is ineffective in these cases. It is commonly prescribed off-label by healthcare providers when anxiety symptoms are significant and co-occurring with MDD.

Clinical Studies and Evidence

Several clinical trials and clinical studies have explored the effects of desvenlafaxine (Pristiq) on anxiety symptoms. While results are mixed, some evidence suggests that patients experience reduced anxiety symptoms when treated with Pristiq, particularly if they also have depression. In a 2009 study published in Psychopharmacology, patients treated with desvenlafaxine showed significant improvement in anxiety symptoms compared to placebo.[3]

However, it’s worth noting that Pristiq is not typically the first-line treatment for anxiety disorders. SSRIs like sertraline, paroxetine, or escitalopram are more commonly prescribed due to their established efficacy and FDA approval for anxiety-related conditions.

Pristiq for Comorbid Anxiety Disorders and Depression

Many individuals diagnosed with major depressive disorder also struggle with anxiety symptoms. In such cases, Pristiq treatment may provide relief for both conditions. Symptoms such as excessive worry, emotional distress, sleep disturbances, and physical symptoms like fatigue or muscle pain can overlap between the two disorders.

Patients with comorbid anxiety may benefit from the dual-action of Pristiq, making it a suitable option in certain treatment plans. That said, every patient’s medical history, symptom profile, and current medications must be carefully evaluated by a healthcare provider before prescribing Pristiq.

Dosage and Administration

The standard starting dose of Pristiq for adults is 50 mg once daily, with or without food. Pristiq dosage may be adjusted depending on how the patient responds, but higher doses are generally not more effective and may increase the risk of side effects.

In patients with renal impairment or kidney disease, dosage adjustments are necessary to avoid accumulation of the drug in the body. Pristiq is not recommended for pediatric patients.

Side Effects and Risks

Like all prescription medications, Pristiq carries a risk of side effects, some of which can be serious. Common side effects include:[4]

  • Nausea
  • Dizziness
  • Insomnia
  • Sexual dysfunction, including erectile dysfunction or decreased libido
  • Increased blood pressure
  • Dry mouth
  • Sweating

One of the more significant concerns with Pristiq is its potential to increase blood pressure. Regular monitoring of blood pressure is essential, especially in patients with high blood pressure or other cardiovascular conditions.

There’s also a risk of serotonin syndrome—a potentially life-threatening condition that can occur when Pristiq is taken in combination with other medications that affect serotonin levels. Symptoms include confusion, agitation, muscle rigidity, and difficulty breathing.[5] This requires immediate medical attention.

Additionally, Pristiq may trigger manic episodes in patients with bipolar disorder, and there is a risk of suicidal thoughts or behaviors, particularly in young adults during the initial stages of treatment.[6]

Withdrawal and Discontinuation

Discontinuing Pristiq abruptly can lead to withdrawal symptoms such as:

  • Dizziness
  • Irritability
  • Nausea
  • Headache
  • Insomnia
  • Sensory disturbances (e.g., “brain zaps”)

To avoid withdrawal symptoms, Pristiq should be tapered slowly under medical supervision. Patients should not stop taking Pristiq without first consulting their doctor.

Drug Interactions and Contraindications

Pristiq has fewer drug interactions than some older antidepressants, but interactions can still occur—especially with other anxiety medications, prescription drugs, and even over-the-counter supplements. For example, combining Pristiq with MAO inhibitors or St. John’s Wort can increase the risk of serotonin syndrome.

Tell your provider about your full medical history, including any allergic reactions, current medications, or history of mental health disorders, before starting Pristiq.

Alternatives to Pristiq for Treating Anxiety

If you’re struggling with anxiety alone (without depression), your doctor may recommend other anxiety treatment options first, such as:

  • Selective serotonin reuptake inhibitors (SSRIs) like sertraline or escitalopram
  • Cognitive behavioral therapy (CBT) or exposure therapy
  • Commitment therapy (ACT – Acceptance and Commitment Therapy)
  • Other prescription medications like buspirone or benzodiazepines (used short-term)

Managing anxiety often requires a comprehensive treatment plan that includes lifestyle modifications, therapy, and sometimes medication.

Get Connected to Professional Anxiety Treatment

While Pristiq is not officially FDA-approved for treating anxiety, it can help reduce anxiety symptoms—especially in individuals with major depressive disorder. Its dual-action on serotonin and norepinephrine may be beneficial in cases where anxiety and depression coexist.

However, because of potential side effects, drug interactions, and risks such as high blood pressure or suicidal ideation, it’s crucial to take Pristiq only under the guidance of a qualified healthcare provider. They can determine if Pristiq aligns with your specific needs, medical profile, and goals for anxiety management.

If you are experiencing acute anxiety, persistent anxiety, or other mental health concerns, contact 1st Step Behavioral Health to explore the most appropriate treatment options available today.

Frequently Asked Questions (FAQ) About Pristiq and Anxiety

1. Can Pristiq be used as a first-line treatment for anxiety disorders?

Pristiq is generally not considered a first-line treatment for standalone anxiety disorders. SSRIs like sertraline or escitalopram are typically preferred due to their FDA approval and established effectiveness for conditions like generalized anxiety disorder and panic disorder. However, Pristiq may be considered when anxiety is present alongside major depressive disorder or when other treatments have been ineffective.

2. How long does it take for Pristiq to start reducing anxiety symptoms?

While individuals may notice some improvement in mood or energy within the first 1–2 weeks, noticeable reductions in anxiety symptoms often take 4 to 6 weeks or longer. Consistent use as prescribed and regular follow-up with a healthcare provider are essential to monitor progress and adjust treatment if needed.

3. What should I do if my anxiety worsens after starting Pristiq?

If anxiety symptoms intensify or become unmanageable, especially during the first few weeks of treatment, it’s important to contact your healthcare provider immediately. In some cases, the medication may need to be adjusted, augmented with therapy, or switched to a different antidepressant. Never stop or change your dose without medical guidance.

4. Can Pristiq be combined with therapy for anxiety treatment?

Yes, combining medication with psychotherapy, such as cognitive behavioral therapy (CBT) or acceptance and commitment therapy (ACT), is often more effective than either approach alone. Therapy can help address thought patterns and behavioral responses, while Pristiq may help regulate the underlying neurochemical imbalances contributing to anxiety.

5. Are there any lifestyle changes that can enhance the effectiveness of Pristiq for anxiety?

Yes. Incorporating regular exercise, a consistent sleep schedule, balanced nutrition, mindfulness practices, and stress reduction techniques can significantly support the effectiveness of Pristiq. These habits can also improve overall emotional resilience and reduce anxiety triggers.

6. Is Pristiq safe to use long-term for anxiety symptoms?

Pristiq can be used long-term under medical supervision, especially when it continues to provide symptom relief and side effects are manageable. Periodic evaluations by your healthcare provider are necessary to assess effectiveness, side effects, and whether continuation is appropriate for your ongoing anxiety management.

References:

  1. The World Health Organization (WHO): Anxiety Disorders
  2. The National Institute on Mental Health (NIMH): Any Anxiety Disorder
  3. Cambridge University Press: Analysis of the Effect of Desvenlafaxine on Anxiety Symptoms Associated with Major Depressive Disorder: Pooled Data from 9 Short-Term, Double-blind, Placebo-Controlled Trials
  4. Medline Plus: Desvenlafaxine
  5. The National Alliance on Mental Illness (NAMI): Desvenlafaxine (Pristiq)
  6. The National Library of Medicine (NLM): Mania possibly induced by desvenlafaxine

Jump to a Section

Call (855) 425-4846